Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 208 of 5804
-
Organ transplant may offer new hope for rare abdominal cancer patients
Disease control Not yet recruitingThe goal of this prospective phase 2 study is to assess the efficacy and safety of intestinal or multivisceral transplantation for participants with PMP not amenable to other curative-intent treatments. Participants will undergo intestinal/multivisceral transplantation. Participa…
Phase: PHASE2 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Smarter scans for breast cancer survivors: could personalized imaging catch recurrences earlier?
Diagnosis Not yet recruitingBreast cancer follow-up after curative treatment is currently based on largely uniform imaging surveillance strategies, despite substantial variation in recurrence risk across patient subgroups. Early detection of recurrences improves prognosis, particularly when detected by imag…
Phase: NA • Sponsor: Umeå University • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
Magic mushroom compound tested for tough depression and addiction
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if a single dose of psilocybin (5mg Vs 10mg Vs 25mg) alongside psychotherapy is safe and can help treat treatment resistant depression (TRD) with co-occurring substance use disorder (SUD) in veterans and first responders. We seek to ans…
Phase: PHASE1, PHASE2 • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Could a common diabetes drug help fight a deadly lung disease?
Disease control Not yet recruitingThis is a randomized, placebo-controlled trial of metformin in 400 participants with idiopathic pulmonary fibrosis (IPF) who are at high risk of adverse clinical outcomes based on a proteomic classifier. The primary objective is to assess the safety and efficacy of metformin comp…
Phase: PHASE3 • Sponsor: University of Massachusetts, Worcester • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New drug aims to halt Alzheimer's decline in Early-Stage patients
Disease control Not yet recruitingThe primary purpose of the study is to assess if treatment with TML-6 for 52 weeks will be effective in slowing, stopping, or improving cognitive and functional decline in participants with early Alzheimer's Disease (AD) as compared to participants receiving placebo.
Phase: PHASE2 • Sponsor: Merry Life Biomedical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Zapping pancreatic tumors without surgery: a safer approach?
Disease control Not yet recruitingThis clinical trial tests the safety and feasibility of endoscopic ultrasound-guided pulsed electric field ablation for the treatment of pancreatic neoplasms. Pancreatic cancer is a fatal disease that is difficult to diagnose at an early stage. The approach for pancreatic neoplas…
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Weight-Loss drug mounjaro could keep hearts in rhythm after ablation
Disease control Not yet recruitingThis multicenter, randomized, open-label, blinded-endpoint trial evaluates whether weekly subcutaneous tirzepatide for 12 months reduces atrial fibrillation (AF) recurrence after catheter ablation in adults with obesity and heart failure with preserved ejection fraction (HFpEF). …
Phase: PHASE4 • Sponsor: Yunlong Wang • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a pill cut transfusions for sickle cell patients?
Disease control Not yet recruitingThe primary objective of this study is to determine the effect of mitapivat versus placebo on the need for transfusions in subjects with SCD.
Phase: PHASE3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New trial puts mirikizumab Head-to-Head with standard Crohn's therapy
Disease control Not yet recruitingThe choice of drug therapy for Crohn's disease depends on several factors, such as the severity of the condition, the sections of the bowel affected, or the patient's previous treatment history. Conventional therapy consists of a short course of corticosteroid treatment followed …
Phase: PHASE4 • Sponsor: University Hospital Schleswig-Holstein • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New hope for rare immune disorders: upadacitinib trial launches
Disease control Not yet recruitingThis study focuses on a genetic condition that affects the Janus Kinase-Signal Transducer and Activator of Transcription (JAK-STAT) immune signaling pathway. A specific change in the DNA leads to overactivation of this pathway, which can result in immune dysregulation and related…
Phase: PHASE1, PHASE2 • Sponsor: Lisa Satter • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could looser jaundice rules spare preterm babies unnecessary treatment?
Disease control Not yet recruitingRationale: Neonatal hyperbilirubinemia is highly prevalent in very preterm infants born \<30 weeks. Since 2008, uniform Dutch phototherapy thresholds for preterm infants have been used nationwide, largely based on consensus. Consequently, \>80% of very preterm infants receive pho…
Phase: NA • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Virtual reality could help stroke survivors walk again in the real world
Disease control Recruiting nowThe purpose of this study is to evaluate a new virtual reality (VR)-based rehabilitation program designed to help stroke survivors improve their walking abilities in real-world settings. By comparing immersive VR-assisted overground gait therapy to contemporary non-immersive, tre…
Phase: NA • Sponsor: Indiana University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could ketamine beat opioids for sickle cell pain in kids?
Symptom relief Not yet recruitingThe goal of this study is to learn if Ketamine works more efficiently, as compared to Opioids, for Sickle Cell Pain The main questions it aims to answer are: Does Ketamine lower the number of times participants need to be admitted for continued pain control during a Sickle Cell …
Phase: PHASE4 • Sponsor: University of Mississippi Medical Center • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC
-
AI reads brain tumor types from routine slides, no special stains needed
Knowledge-focused Not yet recruitingThis is a multi-center, retrospective, observational study to develop and internally validate an artificial intelligence (AI) foundation model for hierarchical classification of central nervous system (CNS) tumors using approximately 20,000 hematoxylin and eosin (H\&E) whole-slid…
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Could a stronger first dose of targeted radiation beat back advanced prostate cancer?
Disease control Not yet recruitingThis phase I trial studies the safety, side effects, and treatment cycle 1 best dose of Lu-177-PSMA-617 in patients with prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels (castration-resistant) and has spread from wh…
Phase: PHASE1 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Weight-Loss drug may curb stimulant cravings, brain scans suggest
Disease control Not yet recruitingThis open label pilot study will assess the feasibility and preliminary efficacy of tirzepatide which will be prescribed under its FDA approved weight management indication in adults with moderate or severe methamphetamine, cocaine or prescription stimulant use disorder (MUD) who…
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Herbal granules aim to revive immune system in HIV patients
Disease control Not yet recruitingThis pragmatic randomized controlled trial evaluates whether Fuyang Jiedu Granules combined with antiretroviral therapy (ART) improves immune reconstitution in people with HIV who meet criteria for immune reconstitution failure and spleen-kidney yang deficiency syndrome. Eligible…
Phase: NA • Sponsor: Beijing University of Chinese Medicine • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could unclogging brain arteries prevent strokes?
Disease control Not yet recruitingComparison of the efficacy and safety of endovascular treatment versus medical treatment in patients with chronic intracranial artery occlusion.
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
AI trained on thousands of pancreatic cancer cases could revolutionize diagnosis
Knowledge-focused Not yet recruitingCombining retrospective observational research with artificial intelligence data engineering. Collecting historical electronic medical record data, and through data governance and annotation by artificial medical experts, constructing a structured knowledge base.
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Could a simple blood pressure target during surgery prevent delirium in older patients?
Disease control Not yet recruitingIn older patients having surgery, postoperative delirium (an acute disturbance in awareness, attention, or cognition) is common and associated with short-term and long-term morbidity and mortality. The pathophysiology of postoperative delirium is multifactorial - but presumably i…
Phase: NA • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC